Clinical Trial

Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 23, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this single-arm intervention trial is to determine the feasibility of implementing endoscopic ultrasound-guided pancreatic cyst chemoablation (EUS-PCA) using gemcitabine and paclitaxel for intraductal papillary mucinous neoplasms (IPMN) in two New Zealand tertiary interventional endoscopy centres.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-11-30; most recent amendment 2025-04-21.
Trial Details
NCT Number NCT06162468
Lead Sponsor University of Auckland, New Zealand
Collaborators: Gut Cancer Foundation, New Zealand, North Shore Hospital, New Zealand, Waikato Hospital
Conditions Intraductal Papillary Mucinous Neoplasm of Pancreas
Enrollment 20 participants
Start Date 2025-05-31
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-23